Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer.
Maraveyas A, Waters J, Roy R, Fyfe D, Propper D, Lofts F, Sgouros J, Gardiner E, Wedgwood K, Ettelaie C, Bozas G.
Maraveyas A, et al. Among authors: gardiner e.
Eur J Cancer. 2012 Jun;48(9):1283-92. doi: 10.1016/j.ejca.2011.10.017. Epub 2011 Nov 17.
Eur J Cancer. 2012.
PMID: 22100906
Clinical Trial.